Investigators from Vanderbilt-Ingram Cancer Center and three other cancer centers have identified a link between a rare genetic variant and the risk of developing glioma.
A new 3-D view of the body’s response to infection — and the ability to identify proteins involved in the response — could point to novel biomarkers and therapeutic agents for infectious diseases.
MicroRNA “regulatory networks” generated at Vanderbilt aid search for biomarkers and new drugs to treat glioblastoma, the most common and lethal primary brain tumor.
Smoking is more detrimental to lung function in individuals with high proportions of African ancestry.
Anti-retroviral therapy can prevent tuberculosis, even in people with early HIV disease.
A combination of biomarkers may reveal new clues about causes of and potential interventions for autism.